TGFB1 and systemic lupus erythematosus: Our results demonstrated that anti-FKN antibody treatment significantly inhibited expression of NF-κB p65 and TGFβ, the 24h urine protein level and serum anti-double-stranded DNA antibody level of lupus mice were significantly decreased, and the degree of renal pathological inflammatory reaction was reduced.